Lek Exec Denies Suggestions about Stagnation
Maribor, 10 April - The chairman of Slovenian pharmaceutical company Lek, which was taken over by Swiss Novartis in 2002 and incorporated into Sandoz, Novartis's generics arm, assured daily Vecer in an interview that the company was not stagnating, as some have been suggesting.
The rest of this news item is available to subscribers.
The news item consists of 1.567 characters (without spaces) or 310 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.